{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:42:06Z","timestamp":1761619326718},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":663,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>To investigate the efficacy of a 1\u2010week triple therapy with amoxycillin, clarithromycin, and omeprazole or ranitidine bismuth citrate (RBC) in curing <jats:italic>Helicobacter pylori<\/jats:italic> infection and healing duodenal ulcers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>One hundred and ninety\u2010two consecutive out\u2010patients with duodenal ulcer, in whom <jats:italic>H. pylori<\/jats:italic> infection was confirmed by histology and a urease biopsy test, were randomly assigned to a 1\u2010week treatment with either 400\u2003mg b.d. ranitidine bismuth citrate (RAC group) or 20\u2003mg omeprazole b.d. (OAC group) in combination with 1\u2003g amoxycillin b.d. and 500\u2003mg clarithromycin b.d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Eradication of <jats:italic>H. pylori<\/jats:italic> was successful in 77% (per protocol) and 61% (intention\u2010to\u2010treat) of the patients in the RAC group and in 79% (per protocol) and 70% (intention\u2010to\u2010treat) of those in the OAC group. The difference was not significant. Per protocol analysis showed ulcers were healed in 97% of patients in the RAC group and 96% in the OAC group. Adverse effects were seen in four patients in each group: they caused discontinuation of the therapy in one patient of the OAC group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Eradication rates obtained in this study were lower than those expected on the basis of previously reported studies. The two 1\u2010week treatment regimens were equally effective in healing <jats:italic>H. pylori<\/jats:italic> associated duodenal ulcer disease.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00708.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:41:09Z","timestamp":1047354069000},"page":"325-330","source":"Crossref","is-referenced-by-count":18,"title":["Seven\u2010day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of <i>Helicobacter pylori<\/i> in duodenal ulcer: a multicentre, randomized, single\u2010blind study"],"prefix":"10.1111","volume":"14","author":[{"family":"Spinzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Boni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Bortoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ballardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Minoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"8","article-title":"Current European concepts in the management of Helicobacter pylori infection","volume":"41","author":"The European Helicobacter pylori study group","year":"1997","journal-title":"The Maastricht Consensus Report Gut"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00230.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.23164000.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00047.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00094.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80026-1"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.116287000.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.1996.00251.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00392.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00202.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00224.x"},{"key":"e_1_2_6_14_2","first-page":"15","article-title":"Helicobacter pylori antimicrobial resistance in the UK","volume":"39","author":"Karim ON","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_15_2","first-page":"2213","article-title":"Randomized comparison of Ranitidine Bismuth Citrate\u2010based triple therapies for Helicobacter pylori","volume":"92","author":"Laine L","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00380.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00405.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00367.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00270.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00315.x"},{"key":"e_1_2_6_21_2","first-page":"A93","article-title":"Double\u2010blind study comparing once daily versus twice daily dosage of PPI with amoxicillin\u2013clarithromycin for H. pylori cure","volume":"41","author":"Lamouliatte H","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_22_2","first-page":"A94","article-title":"Evaluation of short term ranitidine versus omeprazole triple therapy regimens for eradication of Helicobacter pylori in duodenal ulcer patients","volume":"41","author":"Ruszniewsky P","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_23_2","first-page":"A216","article-title":"The Mach 2 study: Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome","volume":"112","author":"Megraud F","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_24_2","first-page":"5","article-title":"Mode d\u2019action des macrolides et mecanisme de resistance chez Helicobacter pylori","volume":"12","author":"Megraud F","year":"1997","journal-title":"La Lettre de L\u2019infectiologue"},{"key":"e_1_2_6_25_2","first-page":"A38","article-title":"Short course therapy with amoxicillin, clarithromycin triple for 10 days (ACT\u201010) eradicates H. pylori and heals duodenal ulcer","volume":"39","author":"Wurzer H","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_26_2","first-page":"A251","article-title":"Ranitidine bismuth citrate (RBC) is more effective than omeprazole in the eradication of Helicobacter pylori when co\u2010prescribed with clarithromycin","volume":"112","author":"Par\u00e8 P","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_27_2","first-page":"A92","article-title":"Ranitidine bismuth citrate (RBC) co\u2010prescribed with clarithromycin is more effective in the eradication of Helicobacter pylori than omeprazole with clarithromycin","volume":"41","author":"Megraud F","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_28_2","first-page":"1130","article-title":"Susceptibility of amoxicillin\u2010resistant Helicobacter pylori to different B\u2010lactam antibiotics","volume":"279","author":"Dore MP","year":"1998","journal-title":"DDW, New Orleans"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.1996.00275.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00362.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.1.15"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00708.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00708.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00708.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T16:38:48Z","timestamp":1698597528000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00708.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00708.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00708.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}